Sir David Lane, Ludwig Cancer Research’s Scientific Director, was elected today as a Fellow of the American Association for Cancer Research (AACR). Election as a Fellow is the most prestigious honor bestowed by AACR and recognizes those researchers who have made exceptional contributions to the understanding and treatment of cancer.
Professor Lane is most well known for his landmark discovery of the p53 protein, which functions as a vitally important tumor suppressor involved in preventing cancer. The p53 is mutated or at fault in 50 percent of human cancers. He continues to advance pioneering research with a focus on controlling p53 and identifying targets for developing new cancer therapies that could restore normal function.
David Lane joins 11 of his esteemed Ludwig colleagues who were elected as AACR Fellows in previous years. He will be formally recognized during a ceremony at the AACR Annual Meeting on Friday, April 15, 2016.